NetScientific PLC Result of AGM

RNS Number : 8714V

NetScientific PLC

10 July 2024

 

NetScientific plc

 

("NetScientific", the "Group" or the "Company")

 

Result of Annual General Meeting

 

Change of name of Nominated Adviser and Broker

 

NetScientific Plc (AIM: NSCI), the deep tech and life sciences VC investment group, announces that all resolutions set out in the 2024 Notice of Annual General Meeting sent to shareholders were duly passed at the Company's Annual General Meeting held earlier today.

 

Result of Annual General Meeting

 

Resolutions 1 to 6 were passed as Ordinary Resolutions and Resolution 7 was passed as a Special Resolution. The proxy voting results are as follows:

 

Resolution	For	%	Against	%	Vote Total	Vote Total as % of Issued Share Capital	Withheld*
1.     To receive and adopt the Company's Annual Report and Accounts for the period ended 31 December 2023	5,242,260	100.0%	0	0.0%	5,242,260	21.9%	0
2.     To receive and approve the Directors' Remuneration Report	5,199,678	99.2%	42,570	0.8%	5,242,248	21.9%	12
3.     To reappoint BDO LLP as the auditors for the forthcoming year	5,236,319	99.9%	5,941	0.1%	5,242,260	21.9%	0
4.     To authorise the Audit Committee in determining the Auditors' remuneration	5,242,260	100.0%	0	0.0%	5,242,260	21.9%	0
5.     To confirm the reappointment of Dr Ilian Iliev as a director	5,237,162	99.9%	5,098	0.1%	5,242,260	21.9%	0
6.     To authorise the Directors to allot relevant securities pursuant to section 551 of the Companies Act 2006	5,135,560	98.2%	92,634	1.8%	5,228,194	21.8%	14,066
7.     To disapply pre-emption rights on the allotment of securities or sale of treasury shares in connection with a pre-emptive offer or on allotment of up to 239,458 shares	5,067,937	96.9%	160,257	3.1%	5,228,194	21.8%	14,066

 

* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

 

Change of Name of Nominated Adviser and Broker

 

The Company also announces that its Nominated Adviser and Broker has changed its name to Panmure Liberum Limited following completion of its own corporate merger.

 

For more information, please contact:

 

NetScientific
Ilian Iliev, CEO	Via Belvedere Communications
Panmure Gordon (UK) Limited (NOMAD and Broker)
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance) Rupert Dearden (Corporate Broking)	[phone]
Belvedere Communications John West / Llewellyn Angus / Lily Pearce	[phone]

 

About NetScientific

 

NetScientific plc (AIM: NSCI) is a deep tech and life sciences VC investment group with an international portfolio of innovative companies.

 

NetScientific identifies, invests in, and builds high growth companies in the UK and internationally.

 

The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.

 

NetScientific differentiates itself by employing a capital-efficient investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.

 

NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.

 

www.netscientific.net www.netscientific.net  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RAGRMMLTMTIBMRI